GlassScriptPhysician profile
Paul Boerger
NPI 1538345392
$2,017.44
in general payments reported to CMS, 2019-2025
22 companies · $533 in 2025
The $533 reported for 2025 was more than what 93% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $317 · 2023: $417 · 2024: $455 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $404.68 | 2021-2025 | Azstarys |
| Tris Pharma INC | $337.27 | 2021-2025 | Dyanavel Xr, Onyda Xr |
| Cranial Technologies, INC | $255.89 | 2021-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $149.27 | 2022-2025 | Gardasil 9, Vaxelis, Proquad |
| Pfizer INC. | $145.90 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $100.18 | 2022-2024 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $94.91 | 2024-2025 | |
| Sanofi Pasteur INC. | $91.18 | 2021-2025 | |
| Phadia US INC. | $71.64 | 2023-2025 | Immunocap |
| Alk-Abello, INC | $69.05 | 2025 | Neffy, Odactra, Grastek |
| Takeda Pharmaceuticals U.S.A., INC. | $66.99 | 2021-2022 | |
| Genzyme Corporation | $38.06 | 2023 | |
| Abbott Laboratories | $31.27 | 2023-2025 | Id Now Instrument |
| Kaleo, INC. | $29.59 | 2021-2022 | |
| Urgo Medical North America, LLC | $21.43 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $20.03 | 2021 | |
| Sobi, INC | $19.33 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $16.53 | 2025 | Neffy |
| Seqirus USA INC | $15.30 | 2021 | |
| Vertical Pharmaceuticals, LLC | $14.76 | 2025 | Relexxii |
| Glaxosmithkline, LLC. | $13.30 | 2021 | |
| Genentech USA, INC. | $10.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Boerger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.